KalVista Pharmaceuticals Target Price

See how KALV's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$27

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-01	H.C. WainwrightAndrew Fein	$27	0% upside
2026-04-29	Leerink Partners	$27	0% upside
2026-01-09	H.C. WainwrightAndrew Fein	$37	37% upside
2026-01-06	Needham	$32	18.5% upside
2025-11-11	JMP Securities	$28	3.7% upside
2024-11-05	NeedhamSerge Belanger	$28	3.7% upside
2024-09-06	H.C. WainwrightAndrew Fein	$20	25.9% downside
2024-09-06	Leerink PartnersJoseph Schwartz	$20	25.9% downside
2022-07-08	Needham	$38	40.7% upside

KalVista Pharmaceuticals (KALV) FAQ

Stockcircle tracks target price for KalVista Pharmaceuticals (KALV), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for KalVista Pharmaceuticals's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main KALV overview so you can move from this figure to the surrounding analysis quickly.